Paul R. Sieber, MD, FACS, Author at Grand Rounds in Urology

Paul R. Sieber, MD, FACS

Keystone Urology Specialists

Lancaster, Pennsylvania

Paul Sieber, MD, FACS, is the Medical Director for Clinical Trials at Keystone Urology Specialists in Lancaster, Pennsylvania. Dr. Sieber’s specialties include advanced prostate cancer, bone health, urology research, and general urology. He has spent the majority of his clinical practice focusing on prostate cancer, particularly advanced diseases.

Dr. Sieber earned his Bachelor’s degree in Biology from Purdue University in West Lafayette, Indiana. He earned his medical degree from Indiana University in Bloomington, then completed his internship in General Surgery and a residency in Urology at the M.S. Hershey Medical Center, Penn State University in University Park, Pennsylvania.

Dr. Sieber’s interest in clinical research began shortly after completing his residency, when he received a UCF grant, previously known as AFUD, to study the use of heparin in pelvic lymphadenectomy. For over two decades, Dr. Sieber has been involved with and served as a Principal Investigator for more than 200 clinical trials, the bulk of which have focused on prostate cancer. His work has helped with the investigation of diagnostic tests and treatments for prostate cancer, and he has authored numerous peer-reviewed articles and presented many posters at meetings, including the AUA, ASCO GU, SUO, and SIU. Dr. Sieber is a Fellow of the American College of Surgeons and serves as the Laboratory Medical Director and the Principal Investigator for Clinical Trials for Lancaster Urology.

Talks by Paul R. Sieber, MD, FACS

Reinforcing Consistent Testosterone Suppression in ADT

E. David Crawford, MD, Scott B. Sellinger, MD and Paul R. Sieber, MD, FACS | Jan 2022

E. David Crawford, MD, Scott B. Sellinger, MD, and Paul R. Sieber, MD, discuss reinforcing consistent testosterone suppression in ADT and the role of triptorelin.